SCHEMBL24692934

SCHEMBL24692934

Bc1cncc(Sc2ccccc2)c1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PRMT5 O14744 1/20 0.37
▸ WDR77 Q9BQA1 1/20 0.37
▸ SIRT2 Q8IXJ6 2/20 0.37
▸ SIRT1 Q96EB6 2/20 0.37
▸ SIRT3 Q9NTG7 2/20 0.37
▸ MAOA P21397 3/20 0.35
▸ MAOB P27338 3/20 0.35
▸ HPGD P15428 4/20 0.35
▸ HTT P42858 1/20 0.35
▸ CYP11B1 P15538 1/20 0.35
▸ CYP11B2 P19099 1/20 0.35
▸ DDAH1 O94760 1/20 0.34
▸ NOS1 P29475 1/20 0.34
▸ HTR2C P28335 1/20 0.34
▸ HTR6 P50406 1/20 0.34
▸ ICAM1 P05362 1/20 0.34
▸ SELE P16581 1/20 0.34
▸ ALDH1A1 P00352 3/20 0.33
▸ MCL1 Q07820 1/20 0.33
▸ ABL1 P00519 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4815353 0.76 HTT (0.44) PRMT5WDR77SIRT2SIRT1SIRT3
SCHEMBL16056949 0.72 ATM (0.48) MAOAMAOBHPGDHTTDDAH1
SCHEMBL11479924 0.70 DDAH1 (0.46) MAOAMAOBHPGDHTTCYP11B1
SCHEMBL30849345 0.70 DDAH1 (0.46) MAOAMAOBHPGDHTTCYP11B1
SCHEMBL4814459 0.69 KDR (0.35) PRMT5WDR77SIRT2SIRT1SIRT3
Diphenylsulfane SCHEMBL27611905 0.69 HPGD (0.60) SIRT1MAOAMAOBHPGDHTT
Diphenylsulfane SCHEMBL27714827 0.69 HPGD (0.60) SIRT1MAOAMAOBHPGDHTT
Diphenylsulfane SCHEMBL28332331 0.69 HPGD (0.60) SIRT1MAOAMAOBHPGDHTT
Diphenylsulfane SCHEMBL452 0.69 HPGD (0.60) SIRT1MAOAMAOBHPGDHTT
Diphenylsulfane SCHEMBL7109540 0.69 HPGD (0.60) SIRT1MAOAMAOBHPGDHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11479551-B2 MTA-cooperative PRMT5 inhibitors Mirati Therapeutics, Inc. (US) 2022-10-25 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11479551-B2 MTA-cooperative PRMT5 inhibitors PRMT5, PRMT1, PRMT3 PRMT5 1/4885WDR77 133/4885SIRT2 958/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback